The discussion on the sale of kidneys and organ trafficking raises profound ethical and economic questions. From my perspective, one of the most compelling challenges is balancing the urgent financial needs of impoverished individuals with the risk of exploitation and coercion. The idea that $77,000 could provide significant welfare to a poorer person reflects a utilitarian approach to resource allocation, but it also complicates the morality of commodifying human organs. In practice, many sellers of kidneys or egg donors are often vulnerable groups such as college students struggling financially or single mothers relying on public assistance. This reality makes purely voluntary transactions appear exploitative rather than truly consensual. Policies in places like the US carefully regulate payments to avoid coercive compensation levels, aiming instead to reimburse inconvenience and costs. However, this framework sometimes limits access and fairness, especially for those in desperate financial conditions. I personally believe that any reforms around organ sales need to prioritize the dignity and autonomy of the donor, ensuring adequate safeguards and transparent systems. Moreover, we should not lose sight of broader healthcare inequalities that drive people to consider selling organs in the first place. Addressing social safety nets, poverty alleviation, and healthcare access can reduce the pressure on vulnerable populations to make such difficult decisions. Ultimately, this is not just an economic issue but one deeply rooted in ethics, justice, and human rights. By broadening the conversation to include welfare economics, real-life socioeconomic contexts, and moral responsibility, we can discuss policies that respect individuals while maximizing collective well-being. Education, transparent regulations, and public engagement are critical toward developing balanced approaches in this sensitive domain.